Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis

Journal of Crohn's and Colitis

Volumn 6, Issue 8, 2012, Pages 845-851

  Navaneethan, Udayakumar ^a   Venkatesh, Preethi G K ^a   Lashner, Bret A ^a   Remzi, Feza H ^a   Shen, Bo ^a   Kiran, Ravi P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Dysplasia; Inflammatory bowel disease; Liver transplantation; Primary sclerosing cholangitis; Ulcerative colitis

Indexed keywords

ALKALINE PHOSPHATASE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CHOLESTASIS; COLON BIOPSY; COLON CANCER; COLON RESECTION; COLON TUMOR; COLONOSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DYSPLASIA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LIVER BIOPSY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; ULCERATIVE COLITIS;

ADULT; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; COLONOSCOPY; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RISK FACTORS;

EID: 84864583979     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.01.012     Document Type: Article

References (28)

1. Navaneethan U., Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis 2010 Sep, 16(9):1598-1619.
2. Olsson R., Danielsson A., Jarnerot G., Lindstrom E., Loof L., Rolny P., et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991, 100:1319-1323.
3. BroomeD́ U., Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis 2006, 26:31-40.
4. Loftus E.V., Sandborn W.J., Lindor K.D., Larusso N.F. Interactions between chronic liver disease and inflammatory bowel disease. Inflamm Bowel Dis 1997, 3:288-302.
5. Faubion W.A., Loftus E.V., Sandborn W.J., Freese D.K., Perrault J. Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with PSC. J Pediatr Gastroenterol Nutr 2001, 33:296-300.
6. Loftus E.V., Harewood G.C., Loftus C.G., Tremaine W.J., Harmsen W.S., Zinsmeister A.R., et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005, 54:91-96.
7. Heuschen U.A., Hinz U., Allemeyer E.H., Stern J., Lucas M., Autschbach F., et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 2001, 120:841-847.
8. Joo M., Abreu-e-Lima P., Farraye F., Smith T., Swaroop T., Gardner L., et al. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. Am J Surg Pathol 2009, 33:854-862.
9. Penna C., Dozois R., Tremaine W., Sandborn W., LaRusso N., Schleck C., et al. Pouchitis after ileal pouch anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996, 38:234-239.
10. Shen B., Bennett A.E., Navaneethan U., Lian L., Shao Z., Kiran R.P., et al. Primary sclerosing cholangitis is associated with endoscopic and histologic inflammation of the distal afferent limb in patients with ileal pouch-anal anastomosis. Inflamm Bowel Dis 2011, 17:1890-1900.
11. Katzka I., Brody R.S., Morris E., Katz S. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology 1983, 85:22-29.
12. Broomé U., Löfberg R., Veress B., Eriksson L.S. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995, 22:1404-1408.
13. Kornfeld D., Ekbom A., Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997, 41:522-525.
14. Claessen M.M.H., Vleggaar F.P., Tytgat K.M.A.J., et al. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 2008, 50:158-164.
15. Brentnall T.A., Haggitt R.C., Rabinovitch P.S., et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996, 110:331-338.
16. Pekow J.R., Hetzel J.T., Rothe J.A., Hanauer S.B., Turner J.R., Hart J., et al. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis 2010, 16(8):1352-1356.
17. Shetty K., Rybicki L., Brzezinski A., Carey W.D., Lashner B.A. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999, 94:1643-1649.
18. Thackeray E.W., Charatcharoenwitthaya P., Elfaki D., Sinakos E., Lindor K.D. Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2011 Jan, 9(1):52-56.
19. Bergquist A., Said K., Broome U. Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden. Scand J Gastroenterol 2007, 42:88-93.
20. Itzkowitz S.H., Present D.H. Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:314-321.
21. Navaneethan U, Kochhar G, Venkatesh PG, Lewis B, Remzi FH, Lashner BA, et al. Duration and severity of primary sclerosing cholangitis is not associated with the risk of neoplastic changes in the colon in patients with ulcerative colitis. Gastrointest Endosc.
22. Fausa O., Schrumpf E., Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991, 11:31-39.
23. Kim W.R., Poterucha J.J., Wiesner R.H., LaRusso N.F., Lindor K.D., Petz J., et al. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology 1999, 29:1643-1648.
24. Rex D.K., Johnson D.A., Anderson J.C., Schoenfeld P.S., Burke C.A., Inadomi J.M. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 2009, 104:1613.
25. Sobin L.H. WC. International Union Against Cancer (UICC): TNM classification on malignant tumours 2002, Wiley-Liss. 6th ed.
26. Riddell R.H., Goldman H., Ransohoff D.F., Appelman H.D., Fenoglio C.M., Haggitt R.C., et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983, 14:931-968.
27. Farraye F.A., Odze R.D., Eaden J., Itzkowitz S.H. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010 Feb, 138(2):746-774.
28. Goldstone R., Itzkowitz S., Harpaz N., Ullman T. Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location. Gastrointest Endosc 2011 Nov, 74(5):1087-1093.